Autoimmune hemolytic anemia in a patient with primary ovarian non-Hodgkin's lymphoma.
The primary ovarian lymphoma is a rare disease with poor prognosis. The incidence of autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma is estimated at 3%. However, a substantial portion of the previously reported cases of ovarian lymphoma actually represented ovarian involvement by more diffuse lymphomatous process. If stringent criteria are used for case selection, true primary ovarian lymphoma usually carries a favorable prognosis. We present a primary malignant lymphoma of ovary accompanied by autoimmune hemolytic anemia in a 29-yr-old patient. After ablative surgery, the hemoglobin level and the reticulocyte count were normalized. One year following surgery and chemotherapy, the patient is alive and disease free.
Jung
Chang Kil
CK
Department of Internal Medicine, College of Medicine, Dong-A University, Busan, Korea.
Park
Jong Seung
JS
Lee
Eun Ju
EJ
Kim
Sung Hyun
SH
Kwon
Hyuk Chan
HC
Kim
Jae Seok
JS
Roh
Mee Sook
MS
Yoon
Seoung Kook
SK
Kim
Kyeong-Hee
KH
Han
Jin-Yeong
JY
Kim
Hyo Jin
HJ
D000328:Adult; D000743:Anemia, Hemolytic / Q000276:immunology*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000276:immunology; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D010051:Ovarian Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D011239:Prednisolone / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D011239:Prednisolone